Become a member

Mission, focus and added value:

1

To inform the value chain and stakeholders to raise awareness.

2

To build and organize the ecosystem and collaborative network.

3

To maximize the benefits of technology for the European economy improving citizens’ health.

4

To move Organ-on-Chip technologies from a promise in the laboratory to reality in Europe and the world.

For who?

The European Organ-on-Chip Society brings together a broad audience including the general public and institutions (government, health foundations, charities), the academic research community (universities, research institutes), the pharmaceutical industry, other industries (cosmetics, chemical, environmental toxicity and food industries), hospitals, medical centers and medical practitioners, patients associations, policy makers and testing centers.

Added-value of The European Organ-on-Chip Society?

Better understanding of OoC technologies, applications and challenges

Benefit from updated information on OoC

Connect with experts from a wide range of backgrounds involved with OoC

Who are the initiators?

EUROoCS was initiated by the ORCHID (Organ-on-Chip in Development) European consortium of seven academic partners with the aim of:

Creating a road-map for OoC technology,
Building a network of academia, research institutes, industry and regulatory bodies,
Raising awareness and building an ecosystem for OoC technologies.

The First EUROoCS Board:
• Christine Mummery (chair; Leiden University Medical Center, the Netherlands)
• Peter Loskill (vice-chair; Fraunhofer IGB Stuttgart/University of Tübingen, Germany)
• Janny van den Eijnden-van Raaij (secretary/treasurer; hDMT, the Netherlands)
• Albert van den Berg (member; University of Twente, the Netherlands)